Federal grants to Microvascular Therapeutics Inc
Microvascular Therapeutics Inc in Tucson, Arizona received $5.8 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Military Medical Research and Development, with $4.0 million. It had no new grant money in fiscal 2025.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$5.8 million
- Awards4
- Awarded in FY 2025$0
- Largest award$4.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $559,347 |
| FY 2022 | 3 | $1.0 million |
| FY 2023 | 2 | $4.2 million |
| FY 2024 | 0 | -$6 |
| FY 2025 | 0 | $0 |
Programs that fund Microvascular Therapeutics Inc
| Program | Awards | Amount |
|---|---|---|
| Military Medical Research and Development | 1 | $4.0 million |
| Cardiovascular Diseases Research | 2 | $1.4 million |
| Cancer Treatment Research | 1 | $397,597 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Defense | 1 | $4.0 million |
| Department of Health and Human Services | 3 | $1.8 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Ind enabling studies for targeted phase shift microbubbles for sonothrombolysis | Military Medical Research and Development | August 22, 2023 | $4.0 million |
| Ultrasound-mediated thrombolysis for mvo and pao treatment. - abstract encouraging results have been obtained with microbubble (MB) enhanced sonothrombolysis (SL) to treat vascular occlusions in acute st elevation mi (STEMI), peripheral arterial occlusions (PAO) and ischemic stroke. However, there i | Cardiovascular Diseases Research | July 8, 2021 | $925,231 |
| MVT-100 manufacturing and commercialization. - project summary / abstract this commercialization readiness program, crp, (SB1) proposal is directed towards the commercialization of the MVT-100 product as funded by the parent sbir phase II grant (nhlbi phase II sbir, R44HL137447-01). This crp will fu | Cardiovascular Diseases Research | March 23, 2022 | $498,230 |
| Selectivity and efficacy of CD90-TARGETED phase shift microbubbles for hifu-mediated non-thermal ablation of brain tumors. - abstract focused ultrasound (FUS) is a promising non or minimally invasive treatment modality that can permanently destroy tissue deep within the body using thermal necrosis o | Cancer Treatment Research | September 19, 2022 | $397,597 |
Questions people ask
How much federal grant money does Microvascular Therapeutics Inc get?
$5.8 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Microvascular Therapeutics Inc the most?
The Department of Defense, with $4.0 million in 1 award. The Department of Health and Human Services follow.
What is Microvascular Therapeutics Inc's largest federal grant?
$4.0 million under Military Medical Research and Development, with its first action in the period on August 22, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Microvascular Therapeutics Inc?
Its largest are Military Medical Research and Development, Cardiovascular Diseases Research and Cancer Treatment Research.
Other grant recipients in Tucson
- University of Arizona
- Association of Universities for Research in Astronomy, Inc.
- City of Tucson
- Tucson Airport Authority Inc
- Child-Parent Centers, Inc.
- Visionquest National LTD
- SOUTH32 Hermosa Inc
- Pascua Yaqui Tribe
Largest federal grant recipients in Arizona · Federal grants in Arizona